DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

E.E.S. (Erythromycin Ethylsuccinate) - Published Studies


E.E.S. Related Published Studies

Well-designed clinical trials related to E.E.S. (Erythromycin)

Premedication with erythromycin improves endoscopic visualization of the gastric mucosa in patients with subtotal gastrectomy: a prospective, randomized, controlled trial. [2014]

Effectiveness of sequential v. standard triple therapy for treatment of Helicobacter pylori infection in children in Nairobi, Kenya. [2013]

Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial. [2013]

Randomized double-blind crossover study to determine the effects of erythromycin on small intestinal nutrient absorption and transit in the critically ill. [2012]

A comparison between the effectiveness of erythromycin, single-dose clarithromycin and topical fusidic acid in the treatment of erythrasma. [2011.09.18]

[Comparison of maternal and perinatal outcomes in the conservative treatment preterm premature membrane rupture between the use of erythromycin and clindamycin]. [2011.07]

Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. [2011.06]

Meal size can be decreased in obese subjects through pharmacological acceleration of gastric emptying (The OBERYTH trial). [2011.06]

A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities. [2011.05.12]

Biliary excretion of ximelagatran and its metabolites and the influence of erythromycin following intraintestinal administration to healthy volunteers. [2011.05]

Erythromycin to promote bedside placement of a self-propelled nasojejunal feeding tube in non-critically ill patients having pancreatitis: a randomized, double-blind, placebo-controlled study. [2011.04]

Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media. [2011.04]

Evaluation of possible drug-drug interaction between gadoxetic acid and erythromycin as an inhibitor of organic anion transporting peptides (OATP). [2011.02]

Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double-blind, placebo-controlled trial. [2011.02]

Renoprotective effects of clarithromycin via reduction of urinary MCP-1 levels in type 2 diabetic patients. [2011.02]

Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants. [2011]

Erythromycin to promote bedside placement of a self-propelled nasojejunal feeding tube in non-critically ill patients having pancreatitis: a randomized, double-blind, placebo-controlled study. [2011]

Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double-blind, placebo-controlled trial. [2011]

Sub-antibiotic doses of erythromycin as a prokinetic in abdominal surgeries: reviving the old. [2010.12]

Efficacy of prophylactic oral erythromycin to improve enteral feeding tolerance in preterm infants: a randomised controlled study. [2010.12]

Topical nadifloxacin 1% cream vs. topical erythromycin 4% gel in the treatment of mild to moderate acne. [2010.12]

Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial. [2010.12]

Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism. [2010.11]

Effect of 6 Months of Erythromycin Treatment on Inflammatory Cells in Induced Sputum and Exacerbations in Chronic Obstructive Pulmonary Disease. [2010.09.28]

Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study. [2010.08]

Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects. [2010.06]

Erythromycin as an alternative to reduce interfering extra-cardiac activity in myocardial perfusion imaging. [2010.05]

Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris. [2010.05]

Hepatic clearance, but not gut availability, of erythromycin is altered in patients with end-stage renal disease. [2010.04]

Single oral dose of azithromycin versus 5 days of oral erythromycin or no antibiotic in treatment of campylobacter enterocolitis in children: a prospective randomized assessor-blind study. [2010.04]

Azithromycin extended release vs amoxicillin/clavulanate: symptom resolution in acute sinusitis. [2010.01]

[Study of erythromycin and metoclopramide in treatment of feeding intolerance of critically ill patients in intensive care unit] [2010.01]

Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease. [2010]

[Clinical application of azithromycin extended-release (ER) formulation to treat female sexually transmitted infection]. [Article in Japanese] [2010]

Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A beta-haemolytic streptococcal pharyngitis/tonsillitis in adults and adolescents: a double-blind, double-dummy study. [2009.12]

Evaluation of indwelling intravenous catheters for the regional perfusion of the limbs of horses. [2009.10.24]

Evaluation of CYP3A activity in humans using three different parameters based on endogenous cortisol metabolism. [2009.09]

Gefitinib-phenytoin interaction is not correlated with the C-erythromycin breath test in healthy male volunteers. [2009.08]

Pharmacokinetics of azithromycin in plasma and sinus mucosal tissue following administration of extended-release or immediate-release formulations in adult patients with chronic rhinosinusitis. [2009.07]

Erythromycin establishes early oral feeding in neonates operated for congenital intestinal atresias. [2009.04]

Effect of oral erythromycin therapy in patients with aseptic loosening of joint prostheses. [2009.04]

A double blind, randomized, placebo controlled study to evaluate the efficacy of erythromycin in patients with knee effusion due to osteoarthritis. [2009.04]

Irreversible CYP3A inhibition accompanied by plasma protein-binding displacement: a comparative analysis in subjects with normal and impaired liver function. [2009.03]

Generic versus non-generic formulation of extended-release clarithromycin in patients with community-acquired respiratory tract infections: a prospective, randomized, comparative, investigator-blind, multicentre study. [2009]

Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. [2008.12.01]

Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. [2008.10]

Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study. [2008.09]

Pharmacokinetics of azithromycin in serum and sinus fluid after administration of extended-release and immediate-release formulations in patients with acute bacterial sinusitis. [2008.06]

Prevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history. [2008.05.28]

Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin. [2008.04]

Effect of erythromycin and gentamicin on abomasal emptying rate in suckling calves. [2008.01]

Oral amoxicillin vs. oral erythromycin in the treatment of pyoderma in Bamako, Mali: an open randomized trial. [2007.10]

Oral erythromycin accelerates impaired gastrointestinal motility after endoscopic mucosal resection. [2007.09]

Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone. [2007.09]

Oral erythromycin accelerates impaired gastrointestinal motility after endoscopic mucosal resection. [2007.09]

Effect of the treatment period with erythromycin on cytochrome P450 3A activity in humans. [2007.07]

Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma. [2007.06.01]

Effects of uptake and efflux transporter inhibition on erythromycin breath test results. [2007.06]

High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants. [2007.05]

Azithromycin reduces bronchial hyperresponsiveness and neutrophilic airway inflammation in asthmatic children: a preliminary report. [2007.03]

Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness. [2007.02]

Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study. [2007.02]

Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis. [2007.02]

Erythromycin and feeding intolerance in premature infants: a randomized trial. [2007.01]

Pharmacokinetic interaction between voriconazole and methadone at steady state in patients on methadone therapy. [2007.01]

Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin. [2007]

Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease. [2006.09]

The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity. [2006.09]

Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaine. [2006.08]

Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. [2006.06]

Erythromycin promotes gastric emptying during acute pain in volunteers. [2006.06]

Efficacy of oral erythromycin for treatment of feeding intolerance in preterm infants. [2006.05]

Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. [2006.04]

Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers. [2006.02]

Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis. [2006.02]

The effect of erythromycin on video capsule endoscopy intestinal-transit time. [2006.02]

A randomized controlled trial of adjunctive erythromycin in women with idiopathic preterm labor. [2006.01]

Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection. [2006.01]

[Efficacy and safety of extended-release clarithromycin (5-day short-course) vs telithromycin, in acute bacterial exacerbation of chronic bronchitis] [2005.10]

Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults. [2005.10]

Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial. [2005.09.24]

Pharmacokinetics of clarithromycin extended-release (ER) tablets in patients with AIDS. [2005.09]

Efficacy of trimethoprim-sulfamethoxazole compared with sulfadoxine-pyrimethamine plus erythromycin for the treatment of uncomplicated malaria in children with integrated management of childhood illness dual classifications of malaria and pneumonia. [2005.09]

Inhibition of the metabolism of brotizolam by erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in brotizolam metabolism. [2005.08]

Efficacy of telithromycin in community-acquired pneumonia caused by pneumococci with reduced susceptibility to penicillin and/or erythromycin. [2005.07]

The effect of erythromycin and fluvoxamine on the pharmacokinetics of intravenous lidocaine. [2005.05]

[Pharmacokinetics of erythromycin stinoprate capsule] [2005.04]

Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying. [2005.04]

Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways. [2005.03]

Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis. [2005.02]

Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis. [2005.02]

Once daily clarithromycin extended-release vs twice-daily amoxicillin/clavulanate in patients with acute bacterial sinusitis: a randomized, investigator-blinded study. [2005.01]

Effectiveness of syphilis treatment using azithromycin and/or benzathine penicillin in Rakai, Uganda. [2005.01]

Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. [2005.01]

Well-designed clinical trials possibly related to E.E.S. (Erythromycin)

Expression comparison of azithromycin and clarithromycin in triple-therapy regimens for eradication of Helicobacter pylori in hemodialysis patients. [2014]

Long-term macrolide maintenance therapy in non-CF bronchiectasis: evidence and questions. [2014]

Evaluation of subgingivally delivered 0.5% clarithromycin as an adjunct to nonsurgical mechanotherapy in the management of chronic periodontitis: a short-term double blinded randomized control trial. [2014]

Double-blind, randomized, placebo-controlled study of three-month treatment with the combination of ofloxacin and roxithromycin in recent-onset reactive arthritis. [2013]

Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. [2013]

Local drug delivery of 0.5% azithromycin in the treatment of chronic periodontitis among smokers. [2013]

Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial. [2013]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017